South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...

South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...

Just before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...

Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world ...

The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...

The results expose a striking prevalence of high-risk sexual behaviours. Over one-third of participants (34.0%) disclosed ...

The Department of Water and Sanitation (DWS) says it will engage the North West University (NWU) on the study findings of ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...

The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...

A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...